Target Name: KIAA0319
NCBI ID: G9856
Review Report on KIAA0319 Target / Biomarker Content of Review Report on KIAA0319 Target / Biomarker
KIAA0319
Other Name(s): KIAA0319, transcript variant 4 | Dyslexia-associated protein KIAA0319 (isoform a) | 254P1D6B | AAV receptor | Dyslexia-associated protein KIAA0319 (isoform c) | Dyslexia-associated protein KIAA0319 | dyslexia susceptibility 2 | KIAA0319, transcript variant 1 | K0319_HUMAN | Dyslexia susceptibility 2 | KIAA0319 variant 4 | Dyslexia-associated protein KIAA0319 (isoform b) | AAVR | Neuronal migration | DYLX2 | DYX2 | KIAA0319 variant 1 | NMIG | neuronal migration | KIAA0319, transcript variant 3 | KIAA0319 variant 3 | DLX2

KIAA0319: A Potential Drug Target for Various Diseases

KIAA0319 is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues.

Recent studies have identified KIAA0319 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because KIAA0319 is involved in the regulation of cellular processes that are important for the development and progression of these diseases.

One of the reasons why KIAA0319 is thought to be a good candidate for drug treatment is that it is involved in the regulation of the angiogenesis, which is the process by which new blood vessels are formed. In cancer, angiogenesis is often a key factor in the development and progression of the disease. By targeting KIAA0319, researchers hope to disrupt the angiogenic process and inhibit the growth and progression of cancer cells.

Another potential mechanism by which KIAA0319 may be used to treat diseases is its role in the regulation of cellular signaling pathways. KIAA0319 is involved in a number of signaling pathways that are important for the development and maintenance of tissues, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is often disrupted in a variety of diseases, including cancer. By targeting KIAA0319 with drugs that can modulate its activity, researchers hope to restore normal cellular signaling and prevent the development and progression of these diseases.

In addition to its role in cellular signaling pathways, KIAA0319 is also thought to be involved in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells their shape and provides support for the cell, and is involved in many cellular processes, including cell division and movement. KIAA0319 is thought to be involved in the regulation of the cytoskeleton in order to ensure that cells maintain their proper shape and function.

Overall, KIAA0319 is a protein that is involved in a number of important cellular processes that are involved in the development and maintenance of tissues. As a result, it is a potential drug target for the treatment of various diseases. Further research is needed to fully understand the role of KIAA0319 in these processes, and to identify the most effective ways to target its activity with drugs.

Protein Name: KIAA0319

Functions: Involved in neuronal migration during development of the cerebral neocortex. May function in a cell autonomous and a non-cell autonomous manner and play a role in appropriate adhesion between migrating neurons and radial glial fibers. May also regulate growth and differentiation of dendrites

The "KIAA0319 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA0319 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KIAA0319L | KIAA0408 | KIAA0513 | KIAA0586 | KIAA0753 | KIAA0754 | KIAA0825 | KIAA0930 | KIAA1107 | KIAA1143 | KIAA1191 | KIAA1210 | KIAA1217 | KIAA1328 | KIAA1522 | KIAA1549 | KIAA1549L | KIAA1586 | KIAA1614 | KIAA1656 | KIAA1671 | KIAA1671-AS1 | KIAA1755 | KIAA1958 | KIAA2012 | KIAA2013 | KIAA2026 | KICS2 | KIDINS220 | KIF11 | KIF12 | KIF13A | KIF13B | KIF14 | KIF15 | KIF16B | KIF17 | KIF18A | KIF18B | KIF19 | KIF1A | KIF1B | KIF1C | KIF20A | KIF20B | KIF21A | KIF21B | KIF22 | KIF23 | KIF23-AS1 | KIF24 | KIF25 | KIF25-AS1 | KIF26A | KIF26B | KIF27 | KIF28P | KIF2A | KIF2B | KIF2C | KIF3A | KIF3B | KIF3C | KIF4A | KIF4B | KIF5A | KIF5B | KIF5C | KIF6 | KIF7 | KIF9 | KIF9-AS1 | KIFAP3 | KIFBP | KIFC1 | KIFC2 | KIFC3 | Killer Cell Immunoglobulin-Like Receptor (KIR) | Killer cell immunoglobulin-like receptor 2DS1, transcript variant X1 | KIN | Kinesin-like protein KIF16B (isoform 1) | KIR2DL1 | KIR2DL2 | KIR2DL3 | KIR2DL4 | KIR2DL5A | KIR2DL5B | KIR2DP1 | KIR2DS1 | KIR2DS2 | KIR2DS3 | KIR2DS4 | KIR2DS5 | KIR3DL1 | KIR3DL2 | KIR3DL3 | KIR3DP1 | KIR3DS1 | KIR3DX1 | KIRREL1